Bizarre Patents
Reward Candy Dispenser for Personal Computers
A personal computer peripheral, battery powered reward candy dispenser which immediately presents students with a single candy for each problem completed correctly.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 5723496 | Method for prevention and treatment of harmful effects of intracellular acidosis Compounds and a method useful for protection of tissue cells in a mammalian body from irreversible damages due to lactic acidosis caused by oxygen deficiency. The protection is achieved by administering a compound having a cell membrane permeability and/o... | 03/03/1998 |
| 5710326 | Catalyst regeneration process A process for controlling the regeneration of boron trifluoride catalyst complexes in the production of carboxylic acids and other products using boron trifluoride hydrates as a catalyst. Catalyst strength is determined by measuring the electrical conduct... | 01/20/1998 |
| 5710324 | Inhibitors of nitric oxide biosynthesis The present invention is directed to a new class of compound which are useful as inhibitors of the biosynthesis of nitric oxide.... | 01/20/1998 |
| 5681578 | Composition for relieving stress anxiety, grief, and depression A composition for relieving stress, anxiety, grief, and depression includes GABA (gamma amino butyric acid), glutamine, glycine, magnesium, passion flower, primula officinalis, and vitamin B-6.... | 10/28/1997 |
| 5665762 | Decontaminating clinical samples The present invention contemplates methods of decontaminating human fluids prior to processing in the clinical laboratory. The techniques handle large volumes of human serum without impairing the testing results. Novel compounds for photodecontaminating b... | 09/09/1997 |
| 5665766 | Ester of an organic nitrate and a salicylate A pharmaceutical product for the relief of the symptoms of angina pectoris and the like comprises an ester of an organic nitrate and a salicylate or derivative thereof having anti-platelet activity.... | 09/09/1997 |
| 5663182 | Antipsychotic method The present invention relates to a novel method for treating a mammal suffering from or susceptible to schizophrenia and schizophreniform diseases.... | 09/02/1997 |
| 5650174 | Composition for peroral therapy of cognition impairment and a process thereof A solid composition for peroral therapy of cognition impairment is formulated to stabilize the acid labile drug, CI-979 HCl, by layering a mixture of thereof with a binder on mini-sugar spheres, and finally covering the structure with a protective coating... | 07/22/1997 |
| 5643911 | Medicament for therapeutic and prophylactic treatment of diseases caused by smooth muscle cell hyperplasia A method is provided for treating a disease caused by smooth muscle cell hyperplasia. According to this method, there is administered to a patient suffering from said disease a therapeutically or prophylactically effective amount of an aminopyridazine der... | 07/01/1997 |
| 5637749 | Aryl imidate activated polyalkylene oxides Water-soluble aryl imidate activated polyalkylene oxides having improved hydrolytic stability and conjugates of the aryl imidate activated polyalkylene oxides with biologically active nucleophiles are disclosed. Methods of preparing the activated polyalky... | 06/10/1997 |
| 5637765 | Process for the preparation of fluorinated benzoic acids A process for the preparation of 2-chloro-4,5-difluorobenzoic acid and 2,4,5-trifluorobenzoic acid as well as synthetic intermediates useful in and prepared according thereto, comprising reacting a nitrobenzene having the formula ##STR1## wherei... | 06/10/1997 |
| 5622942 | Percutaneous absorptive anesthetic A percutaneous absorptive anesthetic is provided, wherein said anesthetic is formed by mixing a base agent of said anesthetic with one or two type of mixtures which has/have been selected from the groups, for example made of glycyrrhizin, glycyrrhetic aci... | 04/22/1997 |
| 5618842 | N-acyl derivatives of aminoalcohols with polycarboxylic acids able to modulate mast cells in inflammatory processes having neuroimmunogenic origin N-acyl derivatives of aminoalcohols with bicarboxylic or tricarboxylic acids able to modulate the degranulation process consequent to the mast cells activation in inflammatory processes caused by supramaximal stimuli of neurogenic and immunogenic origin.... | 04/08/1997 |
| 5616779 | Process for the preparation of 2,5-di-phenylamino-terephthalic acid and its dialkyl esters The present invention relates to a process for the preparation of 2,5-di-phenylamino-terephthalic acid and its dialkyl esters of the formula ##STR1## in which R is a hydrogen atom or a methyl or an ethyl group, by reaction of a succinic acid dialkyl ... | 04/01/1997 |
| 5616778 | Modified form of bis-1,4-[2'-(2",5"-dimethoxycarbonylphenylazo)-3'-oxobutyramido]benzene and process for its synthesis The compound of the formula ##STR1## having the following CIELAB values: L*=82.55 a*=11.53 b*=90.49 C*=91.22 and H*=82.74.... | 04/01/1997 |
| 5614515 | Lazaroid-based compositions and method for preventing adhesion formation using the same Compositions and method for the minimization or prevention of adhesion formation, whereby an effective amount of at least one lazaroid compound, preferably one of general formula I, is administered for a period of time sufficient to permit tissue repair. ... | 03/25/1997 |
| 5610169 | Pharmaceutical Composition containing slightly water-soluble drug The orally administrable pharmaceutical compositions containing a slightly water-soluble drug, characterized by improved stability and improved absorption of the drug from digestive tract into blood. The use of the compositions of the present invention en... | 03/11/1997 |
| 5604199 | Method of treating fibrosis in skeletal muscle tissue A method of treating skeletal muscle fibrosis in mammals. The novel method is effective for reducing the extent of skeletal muscle fibrosis in an individual who suffers from a disorder which targets skeletal muscle tissue, such as Duchenne's and Becker's ... | 02/18/1997 |
| 5595986 | Stably storable and readily water soluble composition of cephalosporin for injections A stably storable and readily water soluble composition for use in preparing injections and containing Cefditoren, namely a cephalosporin of the formula ##STR1## is now provided, which composition comprises a physical mixture of Cefditoren or a ... | 01/21/1997 |
| 5591889 | Method for the synthesis of trisodium phosphonoformate hexahydrate The present invention relates to a method for the synthesis of foscarnet, i.e. trisodium phosphonoformate hexahydrate, comprising the steps of adding sodium hydroxide to water, heating the aqueous sodium hydroxide solution to 50° C., adding triethyl phos... | 01/07/1997 |
| 5591732 | Medicament for influencing the degree of activation of the central nervous system Use of a medicament with a content of metanolone and/or Oral Turinabol for increasing and optimizing the degree of activation of the central nervous system and/or for prophylaxis and therapy of osteoporosis.... | 01/07/1997 |
| 5583253 | Method of preparing purified alkanesulfonic acid A process of preparing purified alkanesulfonic acid from crude aqueous alkanesulfonic acid containing oxidizable impurities wherein the crude material is treated with a sufficient amount of chlorine to convert the oxidizable impurities to alkanesulfonyl c... | 12/10/1996 |
| 5571534 | Drug formulations for parenteral use This invention relates to parenteral preparations of antiestrogens such as toremifene, desmethyl toremifene, tamoxifen or desmethyltamoxifen. The preparations can be emulsions, liposomes or aqueous solutions of cyclodextrin-drug complexes. Particularly th... | 11/05/1996 |
| 5565408 | Cyanoquinoline compounds Cyanoquinoline compounds Ia or Ib ##STR1## where R1 is CH.dbd.C(CN)2 ; CH.dbd.N--N.dbd.CH--(5-quinolyl); methylsulfonyl; CH.dbd.NOH; halogen; hydroxyl; nitro; cyano; unsubstituted or substituted C1 -C4 -alk... | 10/15/1996 |
| 5565466 | Methods for modulating the human sexual response The invention is directed to improved methods for modulating the human sexual response by administering a vasodilator to the circulation by a route of administration that avoids the "first-pass" effect.... | 10/15/1996 |
| 5563171 | Treatment of glaucoma and ocular hypertension with 댣-adrenergic agonists Substituted 5-2-((2-aryl-2-hydroxyethyl)amino)propyl)-1,3-benzodioxoles having the structural formula: ##STR1## wherein R4, R5, R6, R7, and R8 are as hereinafter defined, are 댣-adrenergic agonists useful in the treatment of elevated intra... | 10/08/1996 |
| 5561164 | Method of treatng protozoal infections caused by microsporidia The present invention relates to pharmaceutical compositions for the treatment of infections caused by Microsporidia comprising treating an animal with 2-[4-(4-chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthoquinone or a physiologically acceptable salt ther... | 10/01/1996 |
| 5559156 | Method for treating animals infected with Babesia spp. The present invention relates to pharmaceutical compositions for the treatment and/or prophylaxis of protozoal infections caused by Kinetoplastida, Apicomplexa, Anaerobic protozoa and Mircosporidia comprising 2-[4-(4-chlorophenyl)cyclohexyl]-3-hydroxy-1,4... | 09/24/1996 |
| 5556638 | Flurbiprofen-containing immediate-effect medicament and its use A medicament for immediately treating painful, inflammatory and/or febrile acute diseases contains flurbiprofen as a racemate, a mixture of a racemate with its enantiomers, a pseudoracemate (mixtures of equal parts of S- and R-flurbiprofen) or as a mixtur... | 09/17/1996 |
| 5556848 | Ophthalmic suspension containing diflupredonate An ophthalmic suspension comprising difluprednate as an active ingredient. The ophthalmic suspension of the present invention shows superior antiinflammatory action and antiallergic action by local administration. Accordingly, the suspension of the presen... | 09/17/1996 |
| 5554358 | Dental compositions with zinc and bicarbonate salts A dental product is provided in a dual-compartment dispenser that includes a first and second composition in respective compartments thereof. The first composition includes a zinc salt while the second composition includes a bicarbonate salt. Preferably t... | 09/10/1996 |
| 5552161 | Low viscosity, highly concentrated surfactant suspension Low viscosity, highly concentrated surfactant suspensions for replacement therapy In diseases of the respiratory tract are described. The suspensions are characterised in that they contain calcium and/or magnesium ions bound to the surfactant and unbound ... | 09/03/1996 |
| 5552404 | Opioid compounds and methods for using same Diarylmethyl piperazine compounds having utility as exogenous receptor combinant species for binding with receptors such as delta, mu, sigma, and/or kappa receptors are disclosed. Compounds of the invention may be employed as conjugates in agonist/antagon... | 09/03/1996 |
| 5549901 | Antimicrobial oil-in-water emulsions An antimicrobial lipid-containing oil-in-water emulsion comprising an agent selected from the group consisting of glycerol monooleate, glycerol trioleate, glycerol monolaurate, and glycerol dilaurate as the primary lipid and a cationic halogen-containing ... | 08/27/1996 |
| 5550127 | Method of treatment for eiph in racing stock The prevention and treatment of exercise-induced pulmonary hemorrhaging in non-human mammals is accomplished by the timely administration of effective amounts of vasodilators, including angiotensin converting enzyme inhibitors such as lisinopril, enalapri... | 08/27/1996 |
| 5547677 | Antimicrobial oil-in-water emulsions An antimicrobial lipid-containing oil-in-water emulsion comprising an agent selected from the group consisting of glycerol monooleate, glycerol trioleate, glycerol monolaurate, and glycerol dilaurate as the primary lipid and a cationic halogen-containing ... | 08/20/1996 |
| 5545616 | Method for predicting and/or preventing preterm labor A method is provided for avoiding premature labor in a pregnant mammal comprising administering to said mammal, during labor, but before an infant is to be delivered, an effective amount of an activin antagonist. In one embodiment, the antagonist is folli... | 08/13/1996 |
| 5545641 | Methods of inhibiting physiological conditions associated with an excess of bradykinin A method of inhibiting a physiological condition associated with an excess of bradykinin comprising administering to a human in need thereof an effective amount of a compound having the formula ##STR1## wherein R1 and R3 are ind... | 08/13/1996 |
| 5543573 | Hydrazinecarboxyamide derivatives, a process for production thereof and uses thereof The present invention relates to a hydrazinecarboxamide derivative of the general formula (I) shown below: ##STR1## wherein the substituents are as defined in the specification, which has a wide insecticidal spectrum at a low dosage, a process for pr... | 08/06/1996 |
| 5539000 | Spray-chilled nabumetone Nabumetone which is spray-chilled and formulated into unit dose forms which have a smaller volume than was previously possible.... | 07/23/1996 |
